Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

KV Emerging From Bankruptcy As Makena Sales Pick Up Steam

Sep 06 2013

• By Brenda Sandburg

Related Content

Former KV Pharmaceutical CEO Sentenced To 30 Days In Jail

Mar 10 2011

Makena’s Orphan Exclusivity Is “Nullified” By FDA’s Compounding Policy, KV Suit Says

Jul 06 2012

KV Pharmaceutical Cleared To Resume Some Drug Shipments, But Cash Crisis Looms

Sep 10 2010

KV Pharmaceutical To Decide Whether To Retain Generics Business After Settling Manufacturing Cover-up Charges With DoJ

Mar 08 2010

Related Companies

Hologic, Inc.

AMAG Pharmaceuticals Inc.

Additional Topics

United States Legal Issues BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window